Contact us

Our Purpose

The primary focus of our work at Seda is to add value to our Clients.

We achieve this through the pragmatic application of scientific excellence in Pharmaceutical Technology and Clinical Pharmacology. Our ambition is for our Pharmaceutical Experts to provide Clients with the experience and level of expertise that may be found in the development functions of major pharmaceutical companies but with the speed and flexibility required in the fast moving biotech sector.

Our knowledge and experience allow us to quickly identify the essential experiments for the phase of development and deliver a suitable data package to meet the regulatory expectations whilst ensuring that the clinical programme has the best chance of success. Equally important is our ability to identify work that can be delayed until after the next value inflection point to ensure that the spend profile is managed appropriately.

Pharmaceutical expert wearing a lab coat looking at samples in a lab

We understand that speed is of the essence, particularly in early stages of development, and our pharmaceutical experts ensure that our systems and processes have the agility to stay off the critical path.

We know that if we can contribute to the value proposition of our Clients, we will play our part in bringing new, innovative therapies to patients.

Seda was founded in 2015 by pharmaceutical experts Paul Dickinson and Marcel de Matas to provide consultancy services across the biotech industry. Company growth has led to an expansion in our capabilities, to include modelling and laboratory services, giving us the ability to take your product from discovery, through early clinical trials and onwards to product approval. This combination of consultancy support by renowned pharmaceutical experts alongside our modelling and laboratory offerings will give you peace of mind that you’re partnered with an organisation that is committed to the quality and the success of your asset. 

Ask our team a question

Expertise:

  • Analytical Sciences
  • Chemical Development
  • CMC Regulatory
  • Complex Medicines

Effi Baetzner

PhD

Director, Quality Control

Effi Baetzner

PhD

Director, Quality Control

View Bio Ask me a question

Effi is a dedicated QC Director at Seda, she is a Principal Scientist and Leader within the pharmaceutical industry. Joining Seda with Line Management responsibilities, she immersed herself in Pharmaceutical Development, gaining valuable insights into the nuanced needs of our clients. In her prior role at a distinguished GxP-accredited CRO, Effi emerged as a leader in analytical testing, specializing in Oligonucleotides and RNA for both commercial and developmental Drug Substance and Product. Drawing on her background as a studied organic chemist, she possesses a wealth of knowledge in small molecules and their comprehensive analysis, cultivated over years of focused expertise. Effi’s multifaceted experience uniquely positions her to understand and address the diverse needs of Seda. As she journeyed from an R&D environment during her studies and PhD to a GxP environment, the understanding and implementation of good quality control processes increased throughout her career and brought her to this exciting opportunity

‪Effi Bätzner‬ – ‪Google Scholar‬

 

Ask me a question

    Expect a reply typically within 48 hours.

    Expertise:

    • Oral Drug Delivery
    • Complex Medicines
    • Paediatric Product Development
    • CMC Regulatory
    • Analytical Sciences

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    Marcel de Matas

    BSc (Hons) PhD FRSC CChem

    Chief Technology Officer & Co-Founder

    View Bio Ask me a question

    Marcel has a track record in a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for introducing the latest science, new technologies (advanced drug delivery and manufacturing) and product design thinking into the Product Development group.

    Marcel has led technical activities, provided project leadership and has managed product development teams responsible for the delivery of drug projects from initial concept design through late stage development, regulatory submission and launch (including advanced drug delivery systems). He has led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and controls (CMC) technical risk and defining product design strategies in early development. Project experience has covered projects across a range of disease and therapy areas with substantial experience in the oncology field.

    ‪Marcel de Matas‬ – ‪Google Scholar‬

    Ask me a question

      Expect a reply typically within 48 hours.

      Expertise:

      • GMP Facilities Management
      • Validation of equipment and Services
      • Drug Product Manufacture
      • API Particle Size Reduction Processing

      Darren Gill

      BTEC HND (Biology)

      Director, Facility Management

      Darren Gill

      BTEC HND (Biology)

      Director, Facility Management

      View Bio Ask me a question

      Prior to joining Seda, I have worked for in the pharmaceutical industry for 26 Years. During this time, I have been involved in R&D Projects across a wide range of Therapeutic areas and in Sterile Manufacturing, Solid Oral Dosage Forms and in Active Pharmaceutical Ingredients (API). I have managed the Facilities team for many years upgrading a number of existing facilities, introducing new equipment, new technologies and services (eg purified water systems, HVAC Systems) as well as System owner for a number of GMP IT systems. In addition, the team I managed ensured the routine cleaning, maintenance and calibration of the Drug Product and API manufacturing plants along with the large High bay warehouse. In the last 2 years before joining Seda I worked within the Development Quality function responsible for the Quality Management System (QMS) and GMP Training.

      Ask me a question

        Expect a reply typically within 48 hours.